癌症中的氨基酸:了解代谢可塑性和差异,以获得更好的治疗方法
Linda K Do1, Hyun Min Lee1, Yun-Sok Ha2
1Department of Urology, Yale School of Medicine, New Haven, CT 06519, USA.
Cell reports
|April 7, 2025
概括
癌细胞重新编程氨基酸代谢,表现出显著的异质性. 了解这种代谢多样性对于开发向疗法和改善瘤学患者治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 癌症新陈代谢 癌症新陈代谢
- 生物化学 生化学
背景情况:
- 代谢重编程是癌症发展的一个关键特征.
- 早期的研究重点是葡萄糖和谷氨胺代谢.
- 新出现的证据强调了氨基酸在癌症生长,免疫力和表观遗传调节中的关键作用.
研究的目的:
- 审查目前关于癌症中氨基酸代谢异质性的研究结果.
- 探索这种代谢多样性的治疗策略的影响.
- 弥合了解癌症代谢灵活性和临床应用之间的差距.
主要方法:
- 关于癌症代谢研究近期进展的文献综述.
- 分析利用新技术研究代谢途径的研究.
- 综合不同瘤类型和微环境中氨基酸利用数据.
主要成果:
- 氨基酸代谢在瘤内和瘤之间高度异质.
- 氨基酸作为重要的能量来源,信号分子和癌症中的表观遗传前体.
- 氨基酸通路中的代谢灵活性影响瘤进展和免疫逃避.
结论:
- 准氨基酸代谢是一个有前途的治疗途径.
- 基于特定氨基酸依赖性的个性化治疗干预可以改善癌症治疗.
- 进一步研究癌症的代谢情景对于推进临床瘤学至关重要.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.6K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Overview of Protein Metabolism
589
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
589
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K


